Arcutis Biotherapeutics, Inc.
ARQT
45 insider filings · Latest: Sep 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 15 7:56 PM | Howard Welgus | Proposed Sale | 4,728 | $26.93 | $127.3K | — | View → |
| Sep 16, 2026 | Sep 18 8:17 PM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Sale | 3,674 | $25.00 | $91.9K | 112,508(D) | View → |
| Sep 15, 2026 | Sep 17 8:06 PM | Howard G. WelgusDirector | Sale | 4,730 | $24.18 | $114.4K | 35,841(D) | View → |
| Sep 16, 2026 | Sep 16 8:08 PM | Larry Todd Edwards | Proposed Sale | 341,980 | $25.00 | $8.5M | — | View → |
| Sep 15, 2026 | Sep 15 8:03 PM | Howard Welgus | Proposed Sale | 4,730 | $24.18 | $114.4K | — | View → |
| Sep 8, 2026 | Sep 10 11:24 PM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Sale | 9,989 | $25.03 | $250.0K | 116,182(D) | View → |
| Sep 8, 2026 | Sep 8 8:41 PM | Masaru Matsuda | Proposed Sale | 13,663 | $25.03 | $341.9K | — | View → |
| Aug 27, 2026 | Aug 28 9:40 PM | Terrie CurranDirector | Sale | 38,200 | $25.03 | $956.1K | 23,526(D) | View → |
| Aug 27, 2026 | Aug 27 8:05 PM | Terrie Curran | Proposed Sale | 38,200 | $25.03 | $956.1K | — | View → |
| Aug 20, 2026 | Aug 24 8:19 PM | Terrie CurranDirector | Sale | 1,072 | $26.04 | $27.9K | 23,526(D) | View → |
| Aug 19, 2026 | Aug 21 8:08 PM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Sale | 1,697 | $27.00 | $45.8K | 117,592(D) | View → |
| Aug 20, 2026 | Aug 20 8:50 PM | Terrie Curran | Proposed Sale | 1,072 | $26.04 | $27.9K | — | View → |
| Aug 17, 2026 | Aug 19 8:57 PM | Howard G. WelgusDirector | Sale | 4,730 | $26.18 | $123.8K | 36,475(D) | View → |
| Aug 19, 2026 | Aug 19 8:27 PM | Patrick Burnett | Proposed Sale | 1,697 | $27.00 | $45.8K | — | View → |
| Aug 17, 2026 | Aug 17 8:28 PM | Howard Welgus | Proposed Sale | 4,730 | $26.18 | $123.8K | — | View → |
| Aug 12, 2026 | Aug 14 12:06 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Sale | 6,700 | $26.08 | $174.8K | 119,289(D) | View → |
| Aug 11, 2026 | Aug 14 12:06 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Sale | 8,300 | $26.52 | $220.1K | 119,289(D) | View → |
| Aug 11, 2026 | Aug 11 9:16 PM | Patrick Burnett | Proposed Sale | 15,000 | $26.52 | $397.8K | — | View → |
| Aug 3, 2026 | Aug 6 1:42 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Sale | 955 | $26.12 | $24.9K | 119,289(D) | View → |
| Aug 3, 2026 | Aug 6 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Sale | 1,230 | $26.12 | $32.1K | 126,171(D) | View → |
Page 1 of 9
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
← Previous
Page 2 of 2